Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Mood Disorders

3,4-methylenedioxyamphetamine has been researched along with Mood Disorders in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brand, S1
Luethi, M1
von Planta, A1
Hatzinger, M1
Holsboer-Trachsler, E1
Marazziti, D1
Dell'osso, B1
Catena Dell'Osso, M1
Dell'Osso, MC1
Consoli, G1
Del Debbio, A1
Mungai, F1
Vivarelli, L1
Albanese, F1
Piccinni, A1
Rucci, P1
Dell'Osso, L1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Mood Disorders

ArticleYear
Romantic love, hypomania, and sleep pattern in adolescents.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2007, Volume: 41, Issue:1

    Topics: Adolescent; Analysis of Variance; Case-Control Studies; Chi-Square Distribution; Emotions; Female; H

2007
Romantic attachment in patients with mood and anxiety disorders.
    CNS spectrums, 2007, Volume: 12, Issue:10

    Topics: Adult; Anxiety Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Lov

2007